Fassò M - Search Results

1

Breaking self-tolerance in nonobese diabetic mice.

Ridgway WM, Fassò M, Lanctot A, Garvey C, Fathman CG. Ridgway WM, et al. Among authors: fasso m. J Exp Med. 1996 Apr 1;183(4):1657-62. doi: 10.1084/jem.183.4.1657. J Exp Med. 1996. PMID: 8666923 Free PMC article.

2

Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo.

Ridgway W, Fassò M, Fathman CG. Ridgway W, et al. Among authors: fasso m. J Immunol. 1998 Jul 15;161(2):714-20. J Immunol. 1998. PMID: 9670947

3

Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.

Ridgway WM, Ito H, Fassò M, Yu C, Fathman CG. Ridgway WM, et al. Among authors: fasso m. J Exp Med. 1998 Dec 21;188(12):2267-75. doi: 10.1084/jem.188.12.2267. J Exp Med. 1998. PMID: 9858513 Free PMC article.

4

T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo.

Fassò M, Anandasabapathy N, Crawford F, Kappler J, Fathman CG, Ridgway WM. Fassò M, et al. J Exp Med. 2000 Dec 18;192(12):1719-30. doi: 10.1084/jem.192.12.1719. J Exp Med. 2000. PMID: 11120769 Free PMC article.

5

A new look at MHC and autoimmune disease.

Ridgway WM, Fassò M, Fathman CG. Ridgway WM, et al. Among authors: fasso m. Science. 1999 Apr 30;284(5415):749, 751. doi: 10.1126/science.284.5415.749. Science. 1999. PMID: 10336398 No abstract available.

6

Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice.

Zhang M, Ju W, Yao Z, Yu P, Wei BR, Simpson RM, Waitz R, Fassò M, Allison JP, Waldmann TA. Zhang M, et al. Among authors: fasso m. J Immunol. 2012 Jun 15;188(12):6156-64. doi: 10.4049/jimmunol.1102604. Epub 2012 May 16. J Immunol. 2012. PMID: 22593619 Free PMC article.

7

SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.

Fassò M, Waitz R, Hou Y, Rim T, Greenberg NM, Shastri N, Fong L, Allison JP. Fassò M, et al. Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3509-14. doi: 10.1073/pnas.0712269105. Epub 2008 Feb 26. Proc Natl Acad Sci U S A. 2008. PMID: 18303116 Free PMC article.

8

Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.

Yu P, Steel JC, Zhang M, Morris JC, Waitz R, Fasso M, Allison JP, Waldmann TA. Yu P, et al. Among authors: fasso m. Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6187-92. doi: 10.1073/pnas.1203479109. Epub 2012 Apr 2. Proc Natl Acad Sci U S A. 2012. PMID: 22474386 Free PMC article.

9

Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy.

Waitz R, Solomon SB, Petre EN, Trumble AE, Fassò M, Norton L, Allison JP. Waitz R, et al. Among authors: fasso m. Cancer Res. 2012 Jan 15;72(2):430-9. doi: 10.1158/0008-5472.CAN-11-1782. Epub 2011 Nov 22. Cancer Res. 2012. PMID: 22108823 Free PMC article.

10

CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection.

Waitz R, Fassò M, Allison JP. Waitz R, et al. Among authors: fasso m. Oncoimmunology. 2012 Jul 1;1(4):544-546. doi: 10.4161/onci.19442. Oncoimmunology. 2012. PMID: 22754781 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters